We are live on
!
Find out more
AWCI
Alpine Woods Capital Investors Portfolio holdings
AUM
$460M
1-Year Est. Return
30.5%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+30.5%
3 Year Est. Return
+104.98%
5 Year Est. Return
+116.86%
10 Year Est. Return
+408.45%
AUM
$901M
AUM Growth
+$81.1M
(+9.9%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
3.03%
Top 10 Holdings %
Top 10 Hldgs %
21.64%
Holding
241
New
22
Increased
73
Reduced
63
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royal Gold
RGLD
|
+$9.01M |
| 2 |
Akamai
AKAM
|
+$7.05M |
| 3 |
Dollar General
DG
|
+$7.03M |
| 4 |
Brookfield Renewable
BEPC
|
+$3.95M |
| 5 |
Amazon
AMZN
|
+$3.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$8.23M |
| 2 |
Plug Power
PLUG
|
+$5.08M |
| 3 |
CME Group
CME
|
+$3.54M |
| 4 |
American Electric Power
AEP
|
+$3.15M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$2.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.82% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 14.69% |
| 4 | Industrials | 11.37% |
| 5 | Consumer Discretionary | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
176
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $601K | 0.07% |
5,000
| – | – |
|
177
Pfizer
PFE
$150B
| $600K | 0.07% |
16,555
-373
| -2% | -$13.2K |
|
178
Vertex Pharmaceuticals
VRTX
$133B
| $598K | 0.07% |
2,784
+3
| +0.1% | +$659 |
|
179
Vanguard Morningstar Growth ETF
VUG
$229B
| $565K | 0.06% |
13,200
| – | – |
|
|
180
American Electric Power
AEP
$67.9B
| $546K | 0.06% |
6,450
-39,107
| -86% | -$3.15M |
|
181
Neurocrine Biosciences
NBIX
$15.9B
| $536K | 0.06% |
5,510
-2,710
| -33% | -$284K |
|
182
Consolidated Edison
ED
$39.9B
| $524K | 0.06% |
7,005
-3,500
| -33% | -$246K |
|
183
Charles River Laboratories
CRL
$13.6B
| $514K | 0.06% |
1,775
-5,200
| -75% | -$1.45M |
|
184
Glacier Bancorp
GBCI
$6.4B
| $514K | 0.06% |
9,000
| – | – |
|
185
Vicor
VICR
$10.4B
| $510K | 0.06% |
6,000
| – | – |
|
186
Illinois Tool Works
ITW
$83.3B
| $488K | 0.05% |
2,201
+44
| +2% | +$9.14K |
|
187
Avery Dennison
AVY
$13.7B
| $477K | 0.05% |
2,600
-13,500
| -84% | -$2.3M |
|
188
Equinix
EQIX
$105B
| $476K | 0.05% |
700
| – | – |
|
189
Logitech
LOGI
$14.8B
| $461K | 0.05% |
4,409
-19,296
| -81% | -$2.03M |
|
190
Invesco S&P SmallCap Health Care ETF
PSCH
$172M
| $460K | 0.05% |
7,500
| – | – |
|
191
Zimmer Biomet
ZBH
$18.7B
| $456K | 0.05% |
2,936
-412
| -12% | -$63.8K |
|
|
ALX
192
Alexander's
ALX
$1.39B
| $445K | 0.05% |
1,603
| – | – |
|
193
IBM
IBM
$222B
| $427K | 0.05% |
3,352
| – | – |
|
194
Teck Resources
TECK
$32.4B
| $422K | 0.05% |
+22,000
| New | +$446K |
|
195
Alexandria Real Estate Equities
ARE
$8.27B
| $407K | 0.05% |
2,475
-200
| -7% | -$33.3K |
|
196
CMS Energy
CMS
$22B
| $398K | 0.04% |
6,500
-1,000
| -13% | -$57.5K |
|
197
Berkshire Hathaway Class A
BRK.A
$1.09T
| $386K | 0.04% |
1
| – | – |
|
198
AC Immune
ACIU
$267M
| $381K | 0.04% |
50,000
| – | – |
|
199
Codexis
CDXS
$175M
| $366K | 0.04% |
16,000
| – | – |
|
200
Gilead Sciences
GILD
$168B
| $362K | 0.04% |
5,600
-200
| -3% | -$12.9K |
|
Similar funds
MCB
FCMV
PC
PIN
AA
AC
UAM
PC
Alpine Woods Capital Investors's Q1 2021 Portfolio in Review
As of Q1 2021, Alpine Woods Capital Investors held 241 positions worth $901M, up 9.9% from $820M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Alpine Woods Capital Investors deployed $27.3M of net new capital in Q1 2021, opening 22 new positions and adding to 73 existing holdings. Its largest new stake was Royal Gold: 84,500 shares worth $9.09M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $8.23M trimmed.
- Alpine Woods Capital Investors's largest Q1 2021 buy was Royal Gold: 84,500 shares worth $9.09M.
- Alpine Woods Capital Investors added most to Dollar General in Q1 2021, an estimated $7.03M increase.
- Alpine Woods Capital Investors's biggest Q1 2021 reduction was SPDR Gold Trust, cutting an estimated $8.23M.
- Alpine Woods Capital Investors fully exited Lakefront Biotherapeutics American Depositary Shares in Q1 2021, selling an estimated $2.53M.
- Alpine Woods Capital Investors's ten largest holdings make up 22% of its $901M portfolio in Q1 2021.
- Alpine Woods Capital Investors opened 22 new positions and closed 9 in Q1 2021.
- Alpine Woods Capital Investors's portfolio value rose 9.9% quarter-over-quarter to $901M.
Based on Alpine Woods Capital Investors's 13F filing for Q1 2021, filed 11 May 2021.